PAVmed
Healthcare, Health Care · 107 employees
PAVmed (NASDAQ: PAVM) is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This model enables us to pursue an expanding pipeline strategy with a view to enhancing and accelerating value
Funding history
- Funding Round — $30.0M — Feb 2026
- Funding Round — $45.0M — Feb 2026
- Series seed — $2.7M — Feb 2025
- Funding Round — $7.8M — Aug 2020
- Funding Round — $4.1M — May 2020
Recent signals
- Apr 02, 2026: PAVmed Appoints Joseph Virgilio as Senior Vice President and Chief Business Officer, Medical Devices
- Feb 17, 2026: Raised $30.0M
- Feb 04, 2026: Raised $45.0M
- Dec 05, 2025: SEC 8-K (5.02): On December 5, 2025, PAVmed Inc. held a special meeting of stockholders where approximately 65.8% of the voting power was present. The stockholders approved a proposal to amend the company's certificate of incorporation to effect a reverse stock split of the outstanding shares of common stock. The specific ratio for the reverse split will range from 1-for-10 to 1-for-30, with the final ratio to be determined by the board of directors. This strategic move aims to enhance the company's stock price and marketability.
- Feb 07, 2025: Raised $2.7M in Series seed
- Aug 11, 2020: Raised $7.8M
- May 01, 2020: Raised $4.1M
- Nov 07, 2019: Raised $14.0M
See plans & pricing → Track PAVmed’s funding, hiring, and signals — with verified contacts — on Fundz.